To finish, I wanted to share some positive stories from people who have used these weight loss drugs in our groups
Constipation may develop as gastric emptying slows more noticeably
Retatrutide is an investigational triple agonist activating GLP-1, GIP, and glucagon receptors simultaneously
Because retatrutide has not received MHRA marketing authorisation, there is currently no official MHRA guidance specifically addressing its dosing, safety profile, or use in clinical practice outside of approved trials
And theyre like, Okay, I dont need to keep losing weight, Ricks said
While these drugs offer impressive results for weight loss and blood sugar control, growing evidence suggests they may come with concerning long-term effects that arent always discussed in the consultation room